Bruno Vanderlinden - Concepedia

Author

Bruno Vanderlinden

Institut Jules Bordet

Also Known As

B Vanderlinden, B. Vanderlinden, Bruno Vanderlinden, Frank Miller, Vanderlinden, B., Vanderlinden, Bruno

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Institut Jules Bordet Université Libre de Bruxelles Université Paris-Saclay Université Paris Cité Centre National de la Recherche Scientifique

About

Bruno Vanderlinden is an author at Institut Jules Bordet specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	731
2	Health Sciences	4	4	461
3	Engineering	1	1	147
4	Cell Biology	1	1	12
5	Gastroenterology	1	1	24

Bruno Vanderlinden

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Tumor Texture Analysis in <sup>18</sup>F-FDG PET: Relationships Between Texture Parameters, Histogram Indices, Standardized Uptake Values, Metabolic Volumes, and Total Lesion Glycolysis Fanny Orlhac, Michaël Soussan, Jacques-Antoine Maisonobe, Journal of Nuclear Medicine	2014	338
Radiosurgery for treatment of brain metastases: Estimation of patient eligibility using three stratification systems José Lorenzoni, Daniel Devriendt, Nicolas Massager, International Journal of Radiation OncologyBiologyPhysics Adaptive RadiotherapyNeuro-oncologyHealth SciencesMedical ImagingRadiation Therapy	2004	289
Multimodality imaging can predict the metabolic response of unresectable colorectal liver metastases to radioembolization therapy with Yttrium-90 labeled resin microspheres Patrick Flamen, Bruno Vanderlinden, Philippe Delatte, Physics in Medicine and Biology Surgical OncologyEngineeringOncologic ImagingMultimodalityResin Microspheres	2008	147
Comparative Assessment of Methods for Estimating Tumor Volume and Standardized Uptake Value in <sup>18</sup>F-FDG PET Perrine Tylski, Simon Stute, Nicolas Grotus, Journal of Nuclear Medicine	2010	138
Tumour targeting and radiation dose of radioimmunotherapy with 90Y-rituximab in CD20+ B-cell lymphoma as predicted by 89Zr-rituximab immuno-PET: impact of preloading with unlabelled rituximab Kristoff Muylle, Patrick Flamen, Daniëlle J. Vugts, European Journal of Nuclear Medicine and Molecular Imaging	2015	102
Serial FDG–PET/CT for early outcome prediction in patients with metastatic colorectal cancer undergoing chemotherapy Alain Hendlisz, V. Golfinopoulos, C. Garcia, Annals of Oncology Early Outcome PredictionOncologic ImagingMedical ImagingGastrointestinal OncologyMedicine	2011	77
Dual [68Ga]DOTATATE and [18F]FDG PET/CT in patients with metastatic gastroenteropancreatic neuroendocrine neoplasms: a multicentre validation of the NETPET score David Chan, Aimee R. Hayes, Ioannis Karfis, British Journal of Cancer	2022	76
Personalised radioembolization improves outcomes in refractory intra-hepatic cholangiocarcinoma: a multicenter study Hugo Levillain, Ivan Duran Derijckere, Lieveke Ameye, European Journal of Nuclear Medicine and Molecular Imaging Refractory Intra-hepatic CholangiocarcinomaSurgical OncologyHepatologyMedicineHepatobiliary Tumor	2019	71
Multicenter Harmonization of <sup>89</sup>Zr PET/CT Performance Nikolaos Makris, Ronald Boellaard, Eric P. Visser, Journal of Nuclear Medicine	2013	69
A dosimetry procedure for organs-at-risk in 177Lu peptide receptor radionuclide therapy of patients with neuroendocrine tumours Gwennaëlle Marin, Bruno Vanderlinden, Ioannis Karfis, Physica Medica	2018	60

Page 1